Annual Congress Copenhagen 2005


Material from 2005:
  • 4063 Abstracts
  • 739 Slide presentations
  • 213 Webcasts
  • 93 Handouts
Material from 2005:  Show


Various aspects of pulmonary fibrosis

Thematic Poster Session
Chairs: C. Albera (Orbassano, Italy), P. Haslam (London, United Kingdom)


Download all media Download all media
 [+]  Congress or journal article abstract 2187 The role of hepatitis C virus infections in idiopathic pulmonary fibrosis
E. C. Seyhan, E. Cetinkaya, S. Altin, G. Safak, E. Kucukates, S. Timur (Istanbul, Turkey)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2188 Genes of glucocorticoid receptor and glutathione-S-transferase in patients with idiopathic pulmonary fibrosis
Y. M. Ilkovich, L. N. Novikova, T. E. Gembitskaya, V. I. Trofimov, M. V. Dubina, E. D. Yanchina (St. Petersburg, Russian Federation)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2189 Epstein-Barr virus specific antibodies in patients with idiopathic pulmonary fibrosis and presence of EBV in respiratory tract: reactivation of infection?
M. Bukowczan, J. Soja, M. Sanak, M. Duplaga, K. Sladek, A. Szczeklik (Cracow, Poland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2190 Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis
M. Plataki, K. M. Antoniou, M. G. Alexandrakis, K. Sfiridaki, N. Tzanakis, E. Tzortzaki, N. M. Siafakas, D. Bouros (Heraklion, Alexandroupolis, Greece)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2191 Angiogenic and angiostatic CXC chemokines in BALF and serum of IPF patients
K. M. Antoniou, E. G. Tzortzaki, N. Tzanakis, K. Sfiridaki, M. G. Alexandrakis, D. Bouros, N. M. Siafakas (Heraklion, Alexandroupolis, Greece)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2192 Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis
E. Anaev, S. Avdeev, A. Cherniak, Z. Merzhoeva, A. Chuchalin (Moscow, Russian Federation)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2193 Lung compliance in early pulmonary fibrosis
G. Ciarleglio, M. R. Refini, M. G. Pieroni, V. A. Martino, E. Vlad, P. Rottoli, P. Sestini (Siena, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2194 Functional and prognostic significance of relationship between VC and TLC in patients with idiopathic pulmonary fibrosis (IPF)
S. Wesolowski, M. Franczuk, P. Boros, J. Kus (Warsaw, Poland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2195 Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis
V. I. Osipenko, E. N. Popova, E. A. Kogan (Moscow, Russian Federation)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2196 Plasma level of total hydroperoxide (TH) as a marker of oxidative stress seems to be a useful index of disease severity in patients with idiopathic pulmonary fibrosis (IPF)
Z. Daniil, E. Papageorgiou, A. Koutsokera, D. Papadopoulos, T. Kiropoulos, K. Kostikas, K. Gourgoulianis (Larissa, Greece)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2197 Lung function tests and survival in idiopathic pulmonary fibrosis after lung transplantation
A. S. Rubin, R. D. Marques, D. C. Berton, C. Perin, G. Meyer, L. C. Corrêa da Silva, J. J. Camargo (Porto Alegre, Brazil)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2198 Left ventricular diastolic dysfunction in patients with pulmonary fibrosis
G. Pitsiou, H. Karvounis, T. Kontakiotis, T. Karamitsos, E. Dalamanga, I. Stanopoulos, P. Argyropoulou, G. Parharidis, G. Louridas, D. Patakas (Thessaloniki, Greece)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2199 Right ventricular dysfunction in patients with pulmonary fibrosis
G. Pitsiou, H. Karvounis, T. Kontakiotis, T. Karamitsos, E. Dalamanga, D. Papakosta, P. Argyropoulou, G. Parharidis, D. Patakas, G. Louridas (Thessaloniki, Greece)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2200 Does IFN-g slow progression of idiopathic pulmonary fibrosis (IPF)?
I. Esposito, M. Perrella, D. Micera, E. Conte, F. Perna, M. Gilli, M. Bocchino, A. Sanduzzi (Naples, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2201 Serious adverse events (SAEs) of the respiratory tract in patients with idiopathic pulmonary fibrosis (IPF) treated with interferon gamma-1b (IFN-γ 1b) in three trials
J. S. Loutit, S. Safrin, S. Suzuki, W. Z. Bradford (Brisbane, United States Of America)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2202 Antioxidants and extracorporal detoxication in therapy of idiopathic pulmonary fibrosis
L. A. Kolodkina, L. N. Danilov, L. N. Novikova, V. A. Voinov, T. P. Ses (St. Petersburg, Russian Federation)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract 2203 The natural course of systemic sclerosis patients with interstitial lung involvement
B. Musellim, H. Ikitimur, E. Altug, G. Ongen (Istanbul, Turkey)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite